Table 2—

HRs for total mortality according to diabetes and previous myocardial infarction among Onset Study participants, with nondiabetic participants with no previous myocardial infarction representing the reference group

Nondiabetic first myocardial infarctionNondiabetic previous myocardial infarctionDiabetic first myocardial infarctionDiabetic previous myocardial infarction
n*1,132393243153
Unadjusted2.2 (1.7–2.9)2.3 (1.7–3.1)4.6 (3.4–6.3)
Full model1.5 (1.1–2.0)1.7 (1.2–2.3)2.4 (1.7–3.4)
CV mortality1.5 (1.1–2.2)1.8 (1.2–2.6)2.7 (1.8–4.0)
  • Data are HR (95% CI).

  • *

    * History of previous infarction was missing for 14 patients;

  • this model adjusted for age, sex, hypertension, angina, BMI, current smoking, former smoking, educational attainment, race, household income, usual frequency of exertion, abstention from alcohol, use of thrombolytic therapy, use of cardiac medications (aspirin, β-blockers, calcium channel blockers, or angiotensin-converting enzyme inhibitors), and congestive heart failure or ventricular tachycardia during hospitalization;

  • CV mortality indicates mortality from cardiovascular causes.